文献速递复苏、休克与脓毒症消化、代谢与肾脏急症

脓毒症质量改进措施对急诊广谱抗生素使用及结局的影响

Association of a sepsis initiative on broad spectrum antibiotic use and outcomes in an ED population.
PubMed 文献 · Am J Emerg Med · 2023-06-24
一句话结论急诊脓毒症质量改进项目与广谱抗生素使用比例从3.9%升至6.2%相关,随访MDR感染绝对增加0.37%,总体死亡率无变化。

该研究比较了某急诊科在脓毒症质量改进项目实施前后各一个月的所有急诊就诊患者。广谱抗生素使用比例从实施前的3.9%升至实施后的6.2%(p ≤ 0.00001),收住院更常见,但总体死亡率无变化(0.9% vs. 0.8%,p = 0.41)。在654例接受广谱抗生素治疗的患者中,非感染者比例及艰难梭菌感染率无差异,但实施后多药耐药感染增加(0.72% vs. 0.35%,p = 0.0009)。作者认为需进一步研究强化脓毒症方案对所有受影响患者的影响。

要点

  • 脓毒症质量改进项目实施后,急诊广谱抗生素使用比例由3.9%升至6.2%(p ≤ 0.00001)。
  • 实施后收住院更常见,但全急诊人群总体死亡率无变化(0.9% vs. 0.8%,p = 0.41)。
  • 实施后广谱抗生素后多药耐药感染率升高(0.72% vs. 0.35%,p = 0.0009)。
  • 接受广谱抗生素者中,非感染者比例及艰难梭菌感染率在实施前后无差异。

适用人群与场景

  • 某急诊科脓毒症质量改进项目实施前后各一个月的所有急诊就诊患者。
  • 排除孕妇、年龄<18岁、COVID-19感染、临终关怀患者、违背医嘱离院者及预防性使用抗生素者。

研究设计与关键结果

  • 研究类型为质量改进项目前后对照分析;实施前急诊就诊7967例,实施后7407例。
  • 广谱抗生素使用比例实施前3.9%,实施后6.2%(p ≤ 0.00001);实施后收住院更常见。
  • 全急诊人群总体死亡率实施前0.9%,实施后0.8%(p = 0.41),无变化。
  • 排除后共654例接受广谱抗生素治疗者纳入二次分析,两队列基线特征相似。
  • 艰难梭菌感染率及接受广谱抗生素者中非感染者的比例在实施前后无差异。
  • 实施后急诊广谱抗生素后多药耐药感染占全急诊队列的0.72%,实施前为0.35%(p = 0.0009)。

证据类型、等级与局限

  • 证据类型:质量改进项目前后对照分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,脓毒症质量改进项目与急诊广谱抗生素使用比例增加相关,并伴随后续多药耐药感染的绝对小幅增加,但对全急诊人群及接受广谱抗生素亚组的死亡率无明显影响。
  • 作者认为,需进一步研究强化脓毒症方案对所有受影响患者(而非仅脓毒症患者)的影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Sepsis identification and treatment is a priority for emergency department (ED) providers and payors alike. However, aggressive metrics aimed at improving sepsis care could have unintended consequences for patients who do not have sepsis.

METHODS: All ED patient visits for a one month period before and after a quality initiative to increase early antibiotic use in septic patients were included. Overall broad spectrum (BS) antibiotic use, admission rates, and mortality were compared in the 2 time periods. A more detailed chart review was performed on those who received BS antibiotics in the before and after cohorts. Patient were excluded for pregnancy, age < 18, COVID-19 infection, hospice patients, left ED against medical advice, and if antibiotics were given for prophylaxis. In BS antibiotic treated patients, we sought to determine mortality, rates of subsequent multidrug resistant (MDR) or Clostridium Difficile (CDiff) infections and rates of non-infected patients receiving BS antibiotics.

RESULTS: There were 7967 and 7407 ED visits in the pre- and post-implementation periods, respectively. Of those, BS antibiotics were administered in a total of 3.9% pre-implementation and 6.2% post-implementation (p ≤ 0.00001). Admission was more common in the post-implementation period, but overall mortality was unchanged (0.9% pre-implementation and 0.8% post-implementation, p = 0.41). After exclusions, 654 patients treated with BS antibiotics were included in the secondary analyses. Baseline characteristics were similar between the pre-implementation and post-implementation cohorts. There was no difference in the rate of CDiff infection or the proportion of patients receiving BS antibiotics who were not infected, but there was an increase in the post-implementation period in MDR infections after ED BS antibiotics, 0.72% vs. 0.35% of the entire ED cohorts, p = 0.0009.

CONCLUSIONS: We found that a QI sepsis initiative was associated with an increase in the proportion of patients who received BS antibiotics in the ED, and a small absolute increase in associated subsequent MDR infections, with no apparent effect on mortality in all ED patients or the subset treated with BS antibiotics. Further research is needed to assess the impact on all patients affected by aggressive sepsis protocols and initiatives, rather than only those with sepsis.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Flack T, Oaxaca DM, Olson CM, et al. Association of a sepsis initiative on broad spectrum antibiotic use and outcomes in an ED population. Am J Emerg Med. 2023. PMID: 37421813. doi:10.1016/j.ajem.2023.06.013

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。